source
- GSK to cut over 1,200 jobs at Belgian sites as $2.5 bn restructuring continuesGSK announced it will eliminate more than 1,200 positions across its Belgian facilities, following an earlier closure of a German vaccine plant that cut about 650 jobs. The reductions are part of…
- Astellas marks a decade of CLDN18.2 research, eyeing patient selection and treatment sequencingAstellas highlighted a ten‑year journey that took the CLDN18.2 protein from a scientific hypothesis to a validated target in cancer research. The protein, initially noted for its presence on tumor…